Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
| ▸ | ADH7 | P40394 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.34 |
| ▸ | GAPDH | P04406 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1142296 | 1.00 | TSHR (0.39) | TSHRZDHHC7LMNADNM1ABCB1 | |
| SCHEMBL1142572 | 1.00 | TSHR (0.39) | TSHRZDHHC7LMNADNM1ABCB1 | |
| SCHEMBL1142254 | 1.00 | TSHR (0.39) | TSHRZDHHC7LMNADNM1ABCB1 | |
| SCHEMBL11794865 | 0.98 | TSHR (0.36) | TSHRZDHHC7LMNADNM1ABCB1 | |
| SCHEMBL11184033 | 0.91 | — | — | |
| SCHEMBL2187237 | 0.84 | TSHR (0.41) | TSHRLMNADNM1ADH1BADH1C | |
| SCHEMBL1378622 | 0.84 | TSHR (0.41) | TSHRLMNADNM1ADH1BADH1C | |
| SCHEMBL21638858 | 0.84 | TSHR (0.41) | TSHRLMNADNM1ADH1BADH1C | |
| SCHEMBL5177427 | 0.84 | TSHR (0.41) | TSHRLMNADNM1ADH1BADH1C | |
| SCHEMBL9311248 | 0.84 | TSHR (0.41) | TSHRLMNADNM1ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110035995-A1 | BIOFUEL COMPOSITION AND MANUFACTURING PROCESS | BUSCH RAINER | 2011-02-17 | — | — | US | claimed |
| EP-2201156-B1 | BIOFUEL COMPOSITION AND MANUFACTURING PROCESS | BUSCH RAINER (US) | 2013-10-02 | — | — | EP | disclosed |
| US-8444845-B2 | Biofuel composition and manufacturing process | BUSCH RAINER (US) | 2013-05-21 | — | — | US | disclosed |
| US-20110035995-A1 | BIOFUEL COMPOSITION AND MANUFACTURING PROCESS | BUSCH RAINER | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110035995-A1 | BIOFUEL COMPOSITION AND MANUFACTURING PROCESS | FASN, SCD, ADH1A | TSHR 4062/4885ZDHHC7 246/4885LMNA 2230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.